Vimarsana
Biggest News Aggregation in the World

Page 8 - Trials Unit News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Trials Unit. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Trials Unit Today - Breaking & Trending Today

UW Medicine researchers seek participants for Phase 3 clinical trial of a drug to treat monkeypox - Vimarsana News

UW Medicine researchers seek participants for Phase 3 clinical trial of a drug to treat monkeypox

UW Medicine researchers are recruiting participants for a Phase 3 clinical trial of a drug to treat the monkeypox virus.

Trials, travels and tribulations - Vimarsana News

Trials, travels and tribulations

Liz will reflect on a career, both as a statistician and a teacher, which has taken her from London secondary school maths classrooms, through working on UK-based clinical trials, to collaborating on pragmatic trials of health interventions in varied and sometimes challenging settings.

Toronto institution just got federal money to treat people with magic mushrooms - Vimarsana News

Toronto institution just got federal money to treat people with magic mushrooms

Psychedelics aren't just for experimenting teenagers and mystic shamans anymore, as controlled drugs that were once considered dangerous and of no ...

Source: blogto.com
New CAMH study to look at whether 'magic mushrooms' can help treat depression without the high - Vimarsana News

New CAMH study to look at whether 'magic mushrooms' can help treat depression without the high

Can the compound found in magic mushrooms help treat depression without making people high?

Source: cp24.com
The analysis of active-control trials: missing the point - Vimarsana News

The analysis of active-control trials: missing the point

In this talk, Professor Dunn will discuss the analysis of active-control trials with a time-to-event outcome. He will show that the standard metric used in such trials, the rate ratio or rate difference comparing experimental and control arms, may not be the most clinically relevant measure.  An alternative measure will be proposed, which requires specification of one of two unobserved parameters. The problem will be exemplified by studies from HIV pre-exposure prophylaxis, TB preventative treatment, and COVID-19 vaccines.